Anti-inflammatory and Anti-fibrotic Effects of Intravenous Adipose-derived Stem Cell Transplantation in a Mouse Model of Bleomycin-induced Interstitial Pneumonia

Overview

Journal Sci Rep

Specialty Science

Date 2017 Nov 4

PMID 29097816

Citations 39

Authors

Takuya Kotani

Ryota Masutani

Takayasu Suzuka

Katsuhiro Oda

Shigeki Makino

Masaaki Ii

Affiliations

Soon will be listed here.

Abstract

Adipose-derived stem cells (AdSCs) have recently been considered a useful treatment tool for autoimmune disease because of their anti-inflammatory and immunosuppressive effects. We investigated the therapeutic effect of intravenous AdSC transplantation in a mouse model of bleomycin-induced lung injury. AdSCs accumulated in the pulmonary interstitium and inhibited both inflammation and fibrosis in the lung, markedly improving the survival rate of mice with bleomycin-induced lung injury in a cell number-dependent manner. AdSCs inhibited the production of pro-inflammatory cytokines such as TNF-α and IL-12 in activated macrophages, and AdSCs also induced the apoptosis of activated macrophages. AdSCs inhibited the differentiation and proliferation of Th2-type mCD4+ T cells but promoted the differentiation and proliferation of regulatory T cells, suggesting that the phenotypic conversion of T cells may be one of the mechanisms for the anti-inflammatory effect of AdSCs on pulmonary fibrosis. These findings suggest that intravenous AdSCs could be a promising treatment for patients with interstitial pneumonia.

Citing Articles

Advanced progress of adipose-derived stem cells-related biomaterials in maxillofacial regeneration.

Zhang L, Yu Z, Liu S, Liu F, Zhou S, Zhang Y Stem Cell Res Ther. 2025; 16(1):110.

PMID: 40038758 PMC: 11881347. DOI: 10.1186/s13287-025-04191-y.

Adipose-Derived Mesenchymal Stem Cells (ADSCs) Have Anti-Fibrotic Effects on Lung Fibroblasts from Idiopathic Pulmonary Fibrosis (IPF) Patients.

Ouji-Sageshima N, Hiyama A, Kumamoto M, Kitabatake M, Hara A, Furukawa R Cells. 2025; 13(24.

PMID: 39768142 PMC: 11674916. DOI: 10.3390/cells13242050.

Advances in understanding the role of interleukins in pulmonary fibrosis (Review).

He Y, Shen X, Zhai K, Nian S Exp Ther Med. 2024; 29(2):25.

PMID: 39650776 PMC: 11619568. DOI: 10.3892/etm.2024.12775.

Cellular therapies for idiopathic pulmonary fibrosis: current progress and future prospects.

Le N, Dunleavy M, Kumar R, Zhou W, Bhatia S, El-Hashash A Am J Stem Cells. 2024; 13(4):191-211.

PMID: 39308764 PMC: 11411253. DOI: 10.62347/DAKS5508.

Adipose-derived mesenchymal stem cell therapy for connective tissue diseases and complications.

Kotani T, Saito T, Suzuka T, Matsuda S Inflamm Regen. 2024; 44(1):35.

PMID: 39026275 PMC: 11264739. DOI: 10.1186/s41232-024-00348-z.

References

Lee S, Jang A, Kim Y, Cha J, Kim T, Jung S . Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis. Respir Res. 2010; 11:16. PMC: 2827393. DOI: 10.1186/1465-9921-11-16. View

Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon I, Nepomnaschy I . Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010; 5(2):e9252. PMC: 2821929. DOI: 10.1371/journal.pone.0009252. View

Rojas M, Xu J, Woods C, Mora A, Spears W, Roman J . Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 2005; 33(2):145-52. PMC: 2715309. DOI: 10.1165/rcmb.2004-0330OC. View

Cho K, Lee J, Park M, Park H, Yu H, Roh H . Prostaglandin E2 and Transforming Growth Factor-β Play a Critical Role in Suppression of Allergic Airway Inflammation by Adipose-Derived Stem Cells. PLoS One. 2015; 10(7):e0131813. PMC: 4503681. DOI: 10.1371/journal.pone.0131813. View

King Jr T, Bradford W, Castro-Bernardini S, Fagan E, Glaspole I, Glassberg M . A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370(22):2083-92. DOI: 10.1056/NEJMoa1402582. View

Aguilar S, Scotton C, McNulty K, Nye E, Stamp G, Laurent G . Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One. 2009; 4(11):e8013. PMC: 2779453. DOI: 10.1371/journal.pone.0008013. View

Murphy M, Moncivais K, Caplan A . Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013; 45:e54. PMC: 3849579. DOI: 10.1038/emm.2013.94. View

Xie J, Jones T, Feng D, Cook T, Jester A, Yi R . Human Adipose-Derived Stem Cells Suppress Elastase-Induced Murine Abdominal Aortic Inflammation and Aneurysm Expansion Through Paracrine Factors. Cell Transplant. 2016; 26(2):173-189. PMC: 5657756. DOI: 10.3727/096368916X692212. View

. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med. 2000; 161(2 Pt 1):646-64. DOI: 10.1164/ajrccm.161.2.ats3-00. View

10.

Zuk P, Zhu M, Mizuno H, Huang J, Futrell J, Katz A . Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001; 7(2):211-28. DOI: 10.1089/107632701300062859. View

11.

Taha M, Hedayati V . Isolation, identification and multipotential differentiation of mouse adipose tissue-derived stem cells. Tissue Cell. 2010; 42(4):211-6. DOI: 10.1016/j.tice.2010.04.003. View

12.

Yousefi F, Ebtekar M, Soudi S, Soleimani M, Hashemi S . In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis. Immunol Lett. 2016; 172:94-105. DOI: 10.1016/j.imlet.2016.02.016. View

13.

Gregoire C, Lechanteur C, Briquet A, Baudoux E, Baron F, Louis E . Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Aliment Pharmacol Ther. 2016; 45(2):205-221. DOI: 10.1111/apt.13864. View

14.

Hubner R, Gitter W, Mokhtari N, Mathiak M, Both M, Bolte H . Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques. 2008; 44(4):507-11, 514-7. DOI: 10.2144/000112729. View

15.

Anderson P, Souza-Moreira L, Morell M, Caro M, OValle F, Gonzalez-Rey E . Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut. 2012; 62(8):1131-41. DOI: 10.1136/gutjnl-2012-302152. View

16.

Weiss D . Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012. Ann Am Thorac Soc. 2013; 10(5):S45-97. PMC: 3960908. DOI: 10.1513/AnnalsATS.201304-090AW. View

17.

Weiss D, Ortiz L . Cell therapy trials for lung diseases: progress and cautions. Am J Respir Crit Care Med. 2013; 188(2):123-5. PMC: 3778760. DOI: 10.1164/rccm.201302-0351ED. View

18.

Richeldi L, du Bois R, Raghu G, Azuma A, Brown K, Costabel U . Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370(22):2071-82. DOI: 10.1056/NEJMoa1402584. View

19.

Ortiz L, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N . Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A. 2003; 100(14):8407-11. PMC: 166242. DOI: 10.1073/pnas.1432929100. View

20.

Furuhashi K, Tsuboi N, Shimizu A, Katsuno T, Kim H, Saka Y . Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages. J Am Soc Nephrol. 2013; 24(4):587-603. PMC: 3609131. DOI: 10.1681/ASN.2012030264. View